Educational Activities Archives

Filter by Target Audience Information
Filter by Target Audience

Please select the option that best aligns with your profession.

Target Audience
Filter by Topic Information
Filter by Topic

Please select the option that best aligns with your topic of interest.

Click on the plus (+) icon to display subtopics.

Filter by Format Information
Filter by Format

Please select the option that best aligns with your preferred format of training.

Formats
Key Term Search Information
Key Term Search

Use the search bar to enter in the title of a training, or other key terms.

Course and Resource Listing

Back to Filter ^

Practice-Based Guidelines: Buprenorphine in the Age of Fentanyl (PCSS-MOUD Guidance)

Format: Clinical Tool
The purpose of this guide is to provide practical clinical practice-based guidance, based on available research combined with emerging clinical experience, on the use of buprenorphine in the treatment of individuals using fentanyl and other highly potent synthetic opioids. 
Target Audience(s):
Dentists, Interprofessional Teams, Nurses, PAs, Pharmacists, Pharmacy Technicians, Physicians, Psychiatrists, Psychologists, Social Workers, Students and Educators
Topic(s):
Basic Science, Antagonist, Buprenorphine, Buprenorphine, Full Agonists, Laboratory, Medications, Methadone, Methadone, Naltrexone ...
Credit Available:
CE Credit(s): No
Certificate: No

Treatment of Acute Pain in Patients Receiving Buprenorphine/Naloxone

Format: Clinical Tool
How do I manage acute pain in a patient receiving buprenorphine/naloxone (bup/nx; Suboxone, Zubsolv) for the treatment of opioid dependence?
Target Audience(s):
Nurses, PAs, Pharmacists, Physicians, Psychiatrists
Topic(s):
Co-Occurring SUD / Medical Disorders, Acute Pain, Buprenorphine, General Medical Comorbidities, Medications, Opioids, Opioids, Pain, Setting, Treatment ...
Credit Available:
CE Credit(s): No
Certificate: No

TIP 63: Medications for Opioid Use Disorder

Format: Clinical Tool
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
Target Audience(s):
Dentists, Interprofessional Teams, Nurses, PAs, Pharmacists, Physicians, Psychiatrists, Psychologists, Social Workers
Topic(s):
Treatment, Agonist / Partial Agonist Withdrawal, Antagonist, Buprenorphine, Buprenorphine, Full Agonists, Medications, Methadone, Methadone, Naltrexone ...
Credit Available:
CE Credit(s): No
Certificate: No
Organizer(s):
Substance Abuse and Mental Health Services Administration

Medically Supervised Withdrawal (Detoxification) from Opioids

Format: Clinical Tool
Medically supervised withdrawal or “detoxification” is the process of taking a person off an opioid on which he or she is physically dependent. The term detoxification is usually called medically supervised withdrawal management to destigmatize the process.
Target Audience(s):
Nurses, PAs, Physicians, Psychiatrists, Students and Educators
Topic(s):
Withdrawal Management, Agonist / Partial Agonist Withdrawal, Opioids, Setting, Symptomatic Management, Transition to MOUD ...
Credit Available:
CE Credit(s): No
Certificate: No

How Does Injection Naltrexone Work? (Part 2)

Format: Video
Dr. John Mariani, a Providers Clinical Support System Clinical expert, explains what a patient can expect prior to her first dose of injectable naltrexone as an outpatient.
Target Audience(s):
Nurses, Family and Patient, PAs, Pharmacists, Physicians, Psychiatrists, Psychologists, Social Workers
Topic(s):
Treatment, Antagonist, Medications, Naltrexone, Naltrexone, Opioids, Opioids, Opioids, Pharmacology, Setting ...
Credit Available:
CE Credit(s): No
Certificate: No
Organizer(s):
American Academy of Addiction Psychiatry
More Results